Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070418
Filing Date
2025-05-13
Accepted
2025-05-13 16:24:15
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eras-20250331.htm   iXBRL 10-Q 1986872
2 EX-10.1 eras-ex10_1.htm EX-10.1 44598
3 EX-31.1 eras-ex31_1.htm EX-31.1 16331
4 EX-31.2 eras-ex31_2.htm EX-31.2 16364
5 EX-32.1 eras-ex32_1.htm EX-32.1 8998
6 EX-32.2 eras-ex32_2.htm EX-32.2 9285
7 GRAPHIC img200534160_0.jpg GRAPHIC 646546
  Complete submission text file 0000950170-25-070418.txt   11363291

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20250331.xsd EX-101.SCH 1309570
75 EXTRACTED XBRL INSTANCE DOCUMENT eras-20250331_htm.xml XML 2073540
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40602 | Film No.: 25940529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)